- Home
- NATR vs CERS Comparison
NATR vs CERS Comparison
Compare NATR & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATR
- CERS
- Stock Information
- Founded
- NATR 1972
- CERS 1991
- Country
- NATR United States
- CERS United States
- Employees
- NATR N/A
- CERS N/A
- Industry
- NATR Biotechnology: Pharmaceutical Preparations
- CERS EDP Services
- Sector
- NATR Health Care
- CERS Technology
- Exchange
- NATR Nasdaq
- CERS Nasdaq
- Market Cap
- NATR 237.7M
- CERS 276.0M
- IPO Year
- NATR N/A
- CERS 1997
- Fundamental
- Price
- NATR $13.75
- CERS $1.45
- Analyst Decision
- NATR Strong Buy
- CERS Buy
- Analyst Count
- NATR 2
- CERS 1
- Target Price
- NATR $20.50
- CERS $4.00
- AVG Volume (30 Days)
- NATR 66.3K
- CERS 1.1M
- Earning Date
- NATR 11-06-2025
- CERS 11-06-2025
- Dividend Yield
- NATR N/A
- CERS N/A
- EPS Growth
- NATR N/A
- CERS N/A
- EPS
- NATR 0.75
- CERS N/A
- Revenue
- NATR $460,818,000.00
- CERS $192,510,000.00
- Revenue This Year
- NATR $4.88
- CERS $19.07
- Revenue Next Year
- NATR $2.66
- CERS $12.03
- P/E Ratio
- NATR $18.37
- CERS N/A
- Revenue Growth
- NATR 4.33
- CERS 13.25
- 52 Week Low
- NATR $11.01
- CERS $1.12
- 52 Week High
- NATR $18.06
- CERS $2.24
- Technical
- Relative Strength Index (RSI)
- NATR 37.57
- CERS 46.04
- Support Level
- NATR $12.97
- CERS $1.48
- Resistance Level
- NATR $13.99
- CERS $1.54
- Average True Range (ATR)
- NATR 0.42
- CERS 0.08
- MACD
- NATR 0.01
- CERS -0.02
- Stochastic Oscillator
- NATR 42.30
- CERS 17.86
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.